Report date: Apr 30, 2024
Conflict count: 350192
Publisher: Elsevier 
Title count: 938
Conflict count: 15198


==========================================================

Created: 2009-05-21 09:02:03.0
ConfID: 4543609
CauseID: 798200342
OtherID: 1132457241, 1132457439
JT: Journal of Thrombosis and Haemostasis
MD: null, 5 ,9,1995,2007,CORRIGENDA
DOI: 10.1111/j.1538-7836.2007.02703_2.x(Journal) (4543609-N )
DOI: 10.1111/j.1538-7836.2007.02703_1.x(Journal)
==========================================================

Created: 2008-06-18 08:03:38.0
ConfID: 4558312
CauseID: 578881908
OtherID: 578881908
JT: Journal of Thrombosis and Haemostasis
MD: null, 6 ,7,1250,2008,CORRIGENDA
DOI: 10.1111/j.1538-7836.2008.03042_1.x(Journal) (4558312-N )
DOI: 10.1111/j.1538-7836.2008.03042_2.x(Journal)
==========================================================

Created: 2023-01-07 22:06:29.0
ConfID: 6694404
CauseID: 1557371119
OtherID: 1557371117
JT: Journal of Thrombosis and Haemostasis
MD: null, 3 ,null,1,2005,Abstracts
DOI: 10.1111/j.1538-7836.2005.03000.x(Journal) (6694404-N )
DOI: 10.1111/j.1538-7836.2005.0300a.x(Journal)
==========================================================

Created: 2023-01-15 17:34:26.0
ConfID: 6696388
CauseID: 1558201493
OtherID: 168729091
JT: Journal of Thrombosis and Haemostasis
MD: Roussel-Robert, 1 ,11,2450,2003,Factor VIII inhibitors development following introduction of B-domain-deleted recombinant factor VIII in four hemophilia A previously treated patients
DOI: 10.1046/j.1538-7836.2003.0468a.x(Journal) (6696388-N )
DOI: 10.1046/j.1538-7836.2003.00468.x(Journal)